Saudi Arabia Blood Bags Market, By Product Type (Single Blood Bag, Double Blood Bag, Triple Blood Bag, Quadruple Blood Bag, Penta Blood Bag), By Type (Collection Bag, Transfer Bag), By Volume (100ml, 150ml, 250ml, 300ml, 350ml, 400ml, 450ml, 500ml), By Material (PVC, PET, Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centre, Blood Banks, Others) By Region, Competition, Forecast & Opportunities, 2021-2031F

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 15.74 Million
CAGR (2026-2031)	5.28%
Fastest Growing Segment	PVC
Largest Market	Northern & Central
Market Size (2031)	USD 21.43 Million

Market Overview

The Saudi Arabia Blood Bags Market will grow from USD 15.74 Million in 2025 to USD 21.43 Million by 2031 at a 5.28% CAGR. Blood bags are specialized medical devices essential for the safe collection, storage, processing, and transfusion of human blood and its various components, critical for healthcare infrastructure. The Saudi Arabia Blood Bags Market is primarily driven by the increasing prevalence of hematologic and genetic blood disorders, a growing volume of surgical procedures, and substantial government investments in healthcare under the Vision 2030 initiative. According to the Saudi Ministry of Health on World Blood Donor Day in June 2025, Saudis demonstrated a 58% willingness to donate blood, ranking highest globally among 28 countries in a study. This strong propensity for donation directly influences the consistent demand for blood bags across the Kingdom.

However, a significant challenge impeding market expansion is Saudi Arabia's considerable reliance on imported blood bags, which introduces vulnerabilities related to global supply chain disruptions. This import dependence exposes the market to risks such as logistical delays, geopolitical uncertainties, and fluctuations in raw material availability, posing potential threats to the steady supply of these critical medical consumables.

Key Market Drivers

Rising Surgical Volume Drives Blood Bag Demand
The rising volume of surgical procedures significantly drives demand within the Saudi Arabia Blood Bags Market. This factor directly correlates with the need for blood and blood components for transfusions, both during and after operations. As the healthcare system in Saudi Arabia expands its capabilities, more complex and routine surgical interventions are being performed, necessitating a robust supply of blood bags. According to MOH News, December 2025, in its 'Health Minister Highlights Healthcare Achievements at Budget Forum 2026' report, surgical capacity within health clusters almost doubled, rising from a weekly average of 6,000 surgeries to 12,000 in 2025. This substantial increase in surgical activity directly translates to elevated consumption of blood bags for collection, processing, and transfusion purposes. The enhanced operational efficiency and expanded service offerings across public and private hospitals further underscore this trend.

Vision 2030 Investments and Capacity Expansion Boost Blood Bag Demand
Concurrently, substantial government healthcare investments and infrastructure expansion under the Vision 2030 initiative are pivotal in boosting the blood bags market. These investments enhance healthcare accessibility and capacity, directly influencing the demand for medical consumables, including blood bags. New hospital constructions, upgrades to existing facilities, and the establishment of specialized medical centers all contribute to an increased operational scope requiring more blood services. According to MOH News, October 2025, in its 'GHE 2025 Continues With Over $33 Billion In Strategic Health Investments' announcement, USD 8.4 billion was unveiled for new hospital and infrastructure development projects. This large-scale investment supports the expansion of healthcare delivery points and services, consequently driving the need for blood collection and storage equipment. Furthermore, reflecting the general market expansion, in 2025, public hospitals expanded their bed capacity by more than 1,700 beds, with an additional 2,900 beds added in the private sector, according to MOH News.

Download Free Sample Report

Key Market Challenges

Reliance on Imported Blood Bags Undermines Market Stability
Saudi Arabia's considerable reliance on imported blood bags presents a significant challenge to the growth and stability of its blood bags market. This heavy dependence introduces substantial vulnerabilities to global supply chain disruptions, encompassing potential logistical delays, geopolitical uncertainties, and fluctuations in the availability of essential raw materials. Such external factors directly threaten the steady supply of these critical medical consumables.

Regulatory Import Suspensions Impede Market Expansion
The import dependence directly hampers market expansion by creating an unstable supply environment. For instance, according to the Saudi Food and Drug Authority, in 2024, the import suspension rate reached approximately 30% of all inspected medical device factories, highlighting prevalent issues in quality or compliance from international suppliers. These disruptions lead to inconsistent product availability, increased procurement complexities, and potentially higher costs, all of which impede the ability to meet the consistent demand for blood bags across the Kingdom and consequently restrict overall market development.

Key Market Trends

Shift to DEHP-free, biocompatible materials amid tightening safety standards and SFDA guidance
The Saudi Arabia Blood Bags Market is significantly shaped by a pronounced shift towards the adoption of DEHP-free and biocompatible blood bag materials. This trend is driven by increasing awareness of phthalate leaching risks and a growing emphasis on patient safety and regulatory compliance within the Kingdom’s healthcare sector. As healthcare providers prioritize minimizing patient exposure to potentially harmful chemicals, the demand for bags manufactured from alternative, safer materials such as EVA or PVC-alternatives is accelerating. This necessitates manufacturers to innovate and conform to evolving international and local safety standards, impacting product development and procurement strategies. According to the Saudi Food and Drug Authority (SFDA), updated product classification guidance was published on January 20, 2026, becoming applicable on November 20, 2025, which underscores the continuous regulatory push for enhanced safety and quality across medical devices, including blood bags.

Digital tracking and unified traceability to enhance safety and supply-chain efficiency
Concurrently, the integration of digital tracking and traceability solutions represents another pivotal trend influencing the Saudi Arabia Blood Bags Market. This trend aims to enhance the safety, efficiency, and inventory management of blood products throughout the supply chain, from donor to patient. Implementing digital solutions, such as RFID tagging and advanced inventory management software, allows for real-time monitoring of blood bags, minimizing wastage, preventing errors, and ensuring rapid recall capabilities if needed. This also strengthens accountability and adherence to stringent quality controls. According to Maven Regulatory Solutions, January 2026, in its 'Saudi Arabia SFDA & SASO Product Registration Guide 2025' report, Saudi Arabia has implemented stricter product conformity controls and unified digital systems, including SABER, Ghad, SDR, and FRCS, requiring full traceability for medical devices from manufacturing to importation.

Segmental Insights

PVC Blood Bags: Rapid Growth Driven by Cost-Effectiveness and SFDA Compliance
In the Saudi Arabia Blood Bags Market, the Polyvinyl Chloride (PVC) segment is experiencing rapid growth, positioning itself as the fastest-growing material category. This accelerated expansion is primarily driven by PVC's significant cost-effectiveness when compared to alternative materials, offering an economically viable solution for both government and private sector procurement within the Kingdom's extensive healthcare modernization efforts under Vision 2030. Furthermore, PVC blood bags are highly valued for their proven durability, flexibility, and compatibility with various blood components, which contributes to extended storage periods without compromising quality. The material’s ability to be easily sterilized and its robust resistance to contamination align with the rigorous patient safety standards mandated by regulatory bodies, including the Saudi Food and Drug Authority (SFDA), thereby facilitating smoother market entry and broader adoption.

Regional Insights

Northern & Central Region Drives Dominance in Saudi Arabia Blood Bags Market
The Northern & Central region significantly dominates the Saudi Arabia Blood Bags Market due to its substantial demographic concentration and highly advanced healthcare infrastructure. Anchored by the capital city, Riyadh, this region is home to numerous large medical cities and specialized hospitals that cater to a vast patient population. The presence of these sophisticated healthcare facilities and major blood banking operations necessitates a consistently high volume of blood collection and transfusion procedures. This robust activity directly drives the highest demand for blood bags compared to other regions, firmly establishing its leading position within the market. Strategic healthcare investments and key initiatives by the Ministry of Health are also frequently concentrated within this vital economic and medical hub.

Recent Developments

• In October 2024, Terumo Blood and Cell Technologies, a global company active in blood management and with a presence in the Saudi market, introduced its Reveos Automated Blood Processing System. This new product, launched in the U.S., demonstrated the capability to process up to four whole blood units simultaneously, efficiently separating them into platelets, plasma, and red blood cells in a single step. For the Saudi Arabia Blood Bags Market, such technological advancements could drive demand for compatible and advanced multi-compartment blood bags, optimizing component therapy. This innovation supports healthcare providers in enhancing blood product utilization and overall transfusion efficiency.
• In August 2024, the Saudi Ministry of Health launched a unified blood bank system, marking a significant advancement for the Kingdom's healthcare infrastructure. This initiative, a key part of the Health Sector Transformation Program, aimed to enhance the efficiency of blood transfusion services nationwide. The system's implementation involved collaborations with various companies and institutions, which were instrumental in developing these services and promoting blood donation awareness. This digitalization effort directly impacts the Saudi Arabia Blood Bags Market by streamlining donor information, optimizing blood unit management, and ensuring a consistent supply of blood bags across the region for both routine and critical needs.
• In 2024, the influence of Fresenius Kabi's development of a novel blood bag system, utilizing PVC/BTHC (butyryl trihexyl citrate) material, continued to be observed in the Saudi Arabia Blood Bags Market. This advanced blood bag system, initially announced in August 2023, was designed to improve the storage of red blood cells. Its notable efficiency in preserving blood component quality and rare blood types contributed to market growth in the Kingdom. The introduction of such innovative materials by a prominent healthcare company specializing in blood transfusion technologies aimed to provide a superior alternative to traditional DEHP-based systems, thereby enhancing transfusion safety and the viability of blood products within Saudi Arabian healthcare facilities.
• In 2025, a significant trend impacting the Saudi Arabia Blood Bags Market was the increasing adoption of digital health and smart blood systems, including RFID-tagged blood bags and automated donor tracking. Healthcare providers across the Kingdom were increasingly integrating these technologies into blood bags and inventory systems to enhance traceability and compliance with regulatory standards. This development, driven by the objective to minimize human error and reduce wastage, created opportunities for companies offering digitally integrated solutions. The shift towards technology-safeguarded transfusion workflows represents a breakthrough in improving the safety and efficiency of blood collection, storage, and management within Saudi Arabian blood banks and hospitals.

Key Market Players

• Terumo Middle East
• Fresenius Kabi
• Madac International for Medical Products Factory
• RENOLIT
• Abdulla Fouad Group
• Haemonetics Corporation
• Macopharma (Maco Pharma)
• Grifols S.A.
• B. Braun Melsungen AG
• Kiefel Technologies

By Product Type	By Type	By Volume	By Material	By End User	By Region
Single Blood Bag Double Blood Bag Triple Blood Bag Quadruple Blood Bag Penta Blood Bag	Collection Bag Transfer Bag	100ml 150ml 250ml 300ml 350ml 400ml 450ml 500ml	PVC PET Others	Hospitals & Clinics Ambulatory Surgical Centre Blood Banks Others	Eastern Northern & Central Western Southern

Report Scope:

In this report, the Saudi Arabia Blood Bags Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Saudi Arabia Blood Bags Market, By Product Type:

• Single Blood Bag
• Double Blood Bag
• Triple Blood Bag
• Quadruple Blood Bag
• Penta Blood Bag

• Saudi Arabia Blood Bags Market, By Type:

• Collection Bag
• Transfer Bag

• Saudi Arabia Blood Bags Market, By Volume:

• 100ml
• 150ml
• 250ml
• 300ml
• 350ml
• 400ml
• 450ml
• 500ml

• Saudi Arabia Blood Bags Market, By Material:

• PVC
• PET
• Others

• Saudi Arabia Blood Bags Market, By End User:

• Hospitals & Clinics
• Ambulatory Surgical Centre
• Blood Banks
• Others

• Saudi Arabia Blood Bags Market, By Region:

• Eastern
• Northern & Central
• Western
• Southern